Atypic central serous chorioretinopathy in patient treated by systemic corticosteroid therapy

##plugins.themes.academic_pro.article.sidebar##

Published Feb 16, 2015
Download
pdf
Vol. 92 No. 8 (2014): Issue Aug 2014

##plugins.themes.academic_pro.article.main##

Nibrass Chaker
Ahmed ChebiL
Fedra Kort
Bouraoui Rim
Leila El MatrI

##plugins.themes.academic_pro.article.details##

References

  1. Sato H, Ito S, Nagai S, Murasawa A, Wada Y, Murakami S, et al. Atypical severe central serous chorioretinopathy in a patient with systemic lupus erythematosus improved with a rapid reduction in glucocorticoid. Mod Rheumatol 2013 ;23:172-4
  2. Steichen O, Chauveheid MP, Lidove O, Doan S, Papo T Iatrogenic central serous chorioretinopathy during glucocorticoid therapy for temporal arteritis La revue de medicine interne 2006; 27: 702-5.
  3. Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of - -central serous chorioretinopathy. Retina 2002; 22:25-32.
  4. Sharma T, Shah N, Rao M, Gopal L. Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology 2004; 111:1708-14.